CIK: 0001615982 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $1,457,403 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 8,493,321 | $384,747 | 26.4% | $22.03 | +131.5% | COM | 03770N101 |
| OCUL | OCULAR THERAPEUTIX INC | 12,762,462 | $108,991 | 7.5% | $4.57 | +113.3% | COM | 67576A100 |
| ELVN | ENLIVEN THERAPEUTICS INC | 4,026,331 | $90,592 | 6.2% | $18.38 | +41.0% | COM | 29337E102 |
| PRAX | PRAXIS PRECISION MEDICINES I | 989,985 | $76,189 | 5.2% | $43.15 | +67.7% | COM NEW | 74006W207 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,882,709 | $74,432 | 5.1% | $19.32 | +12.6% | COM | 92790C104 |
| ORKA | ORUKA THERAPEUTICS INC | 3,285,620 | $63,708 | 4.4% | $34.16 | -28.6% | COM | 687604108 |
| SYRE | SPYRE THERAPEUTICS INC | 2,685,448 | $62,517 | 4.3% | $17.59 | +66.7% | COM NEW | 00773J202 |
| PHVS | PHARVARIS N V | 3,220,130 | $61,730 | 4.2% | $15.96 | +29.0% | COM | N69605108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 6,249,731 | $52,935 | 3.6% | $8.81 | +17.5% | COM | 483497103 |
| DYN | DYNE THERAPEUTICS INC | 2,173,913 | $51,217 | 3.5% | $11.80 | +150.7% | COM | 26818M108 |
| COGT | COGENT BIOSCIENCES INC | 5,684,411 | $44,338 | 3.0% | $8.47 | +17.7% | COM | 19240Q201 |
| ERAS | ERASCA INC | 16,216,216 | $40,703 | 2.8% | $2.16 | +27.1% | COM | 29479A108 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,744,373 | $38,027 | 2.6% | $17.70 | +45.3% | COM | 252828108 |
| UPB | UPSTREAM BIO INC | 2,295,319 | $37,735 | 2.6% | $22.33 | 0.0% | COM | 91678A107 |
| ORIC | ORIC PHARMACEUTICALS INC | 4,394,527 | $35,464 | 2.4% | $8.55 | +7.3% | COM | 68622P109 |
| ENGN | ENGENE HOLDINGS INC | 5,046,414 | $33,559 | 2.3% | $10.25 | -24.2% | COM | 29286M105 |
| — | MERUS N V | 592,411 | $24,911 | 1.7% | $20.36 | — | COM | N5749R100 |
| — | ASTRIA THERAPEUTICS INC | 2,457,348 | $21,969 | 1.5% | $8.36 | — | COM | 04635X102 |
| — | CIDARA THERAPEUTICS INC | 765,723 | $20,583 | 1.4% | $26.88 | — | COM NEW | 171757206 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,379,965 | $16,808 | 1.2% | $21.29 | -32.5% | COM | 230031106 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 2,952,371 | $16,445 | 1.1% | $19.48 | -59.7% | COM | 35104E100 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 1,609,569 | $16,224 | 1.1% | $11.59 | +3.6% | COM | 04317A107 |
| — | MERSANA THERAPEUTICS INC | 10,257,790 | $14,669 | 1.0% | $1.27 | — | COM | 59045L106 |
| ABVX | ABIVAX SA | 1,345,780 | $9,851 | 0.7% | $11.63 | — | SPONSORED ADS | 00370M103 |
| AQST | AQUESTIVE THERAPEUTICS INC | 2,629,786 | $9,362 | 0.6% | $3.33 | +38.5% | COM | 03843E104 |
| — | APPLIED THERAPEUTICS INC | 9,990,591 | $8,554 | 0.6% | $3.32 | — | COM | 03828A101 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7,635 | 0.5% | $10.07 | +0.3% | CL A ORD SHS | G70077105 |
| TERN | TERNS PHARMACEUTICALS INC | 1,077,090 | $5,967 | 0.4% | $4.28 | +58.3% | COM | 880881107 |
| TSHA | TAYSHA GENE THERAPIES INC | 3,225,180 | $5,580 | 0.4% | $1.87 | +11.1% | COM SHS | 877619106 |
| TRVI | TREVI THERAPEUTICS INC | 1,266,457 | $5,218 | 0.4% | $2.46 | +29.9% | COM | 89532M101 |
| ZURA | ZURA BIO LTD | 2,023,166 | $5,058 | 0.3% | $4.08 | -12.6% | CLASS A ORD SHS | G9TY5A101 |
| IPSC | CENTURY THERAPEUTICS INC | 3,957,186 | $3,997 | 0.3% | $3.84 | -64.5% | COM | 15673T100 |
| CASIF | CASI PHARMACEUTICALS INC | 987,259 | $2,794 | 0.2% | $6.09 | -22.1% | ORD SHS | G1933S101 |
| TNYA | TENAYA THERAPEUTICS INC | 1,555,556 | $2,224 | 0.2% | $4.78 | -53.1% | COM | 87990A106 |
| TENX | TENAX THERAPEUTICS INC | 208,333 | $1,290 | 0.1% | $3.62 | +34.0% | COM NEW | 88032L605 |
| — | GLYCOMIMETICS INC | 3,000,000 | $747 | 0.1% | $0.25 | — | COM | 38000Q102 |
| TIL | INSTIL BIO INC | 33,177 | $633 | 0.0% | $23.54 | +29.5% | COM NEW | 45783C200 |